AlgoDx Sponsored Webinar: SEP-1 Made Simple: Practical Strategies for Compliance and Better Outcomes
Includes a Live Web Event on 04/14/2026 at 11:00 AM (PDT)
Description:
CMS SEP-1 compliance can feel overwhelming, but it doesn't have to be. This sponsored webinar is designed is designed to help U.S. healthcare leaders improve sepsis quality scores while supporting clinical teams and hospital financial performance.
In this session, you'll learn:
- How to streamline SEP-1 bundle compliance within existing clinical workflows
- How an EHR-embedded sepsis management solution enables early detection and compliance
- Actionable steps to boost quality scores and strengthen your bottom line
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Sepsis Alliance gratefully acknowledges the support provided by AlgoDx for this webinar.
David Becedas, M Sc Pharm, MBA
Chief Executive Officer
AlgoDx
David Becedas, M Sc Pharm, MBA, has 25 years of experience driving commercial growth and clinical development in life sciences industries and most recently served as Director at Chiltern, which was acquired by Labcorp.
Pelle Conradi, MD
Chief Medical Officer
Pelle Conradi, MD, Chief Medical Officer at AlgoDx, is an engaged ICU physician dedicated to clinical excellence who champions leveraging cutting-edge AI to advance sepsis care, safety, and quality.
Magnus Pierrau, M Sc ML
Head of ML and Backend Engineering
Magnus Pierrau, M Sc ML, is an experienced ML engineer with a background in defense and security research as well as medtech, who combines research with practical applications, focusing on data and model development.
Bailey Larson, BSN, RN, CV-BC
Sr. Clinical Product Specialist
AlgoDx
Bailey Larson, BSN, RN, CV-BC, is an innovative sepsis expert with proficiency in sepsis data analysis to drive multidisciplinary process changes, actively engaging in reimbursement, length of stay, education, and research.